[ad_1]
On the afternoon of the 25th, citizens wait in line for influenza vaccination at the Seoul East Branch of the Health Promotion Clinic of the Korea Health Management Association in Dongdaemun-gu, Seoul. The Korea Centers for Disease Control and Prevention (KCDC) announced that children under 12 years of age and pregnant women among children under 12 years of age and pregnant women from the suspended flu vaccine-free vaccination program temporarily from the 22nd they will resume vaccination from this afternoon. 2020.9.25 / News1 © News1 The Centers for Disease Control and Prevention’s Centers for Disease Control and Prevention announced on the 30th that there were 1,362 people who received the influenza (flu) vaccine under investigation because they were suspected of being exposed to temperature. ambient. This is an increase of 489 people compared to the 873 surveyed the day before.
Among them, 122 people were confirmed to have been vaccinated at a nursing hospital in Incheon. There were no reports of adverse reactions and three deaths occurred, but it was found that there was no association with the vaccine.
Of the 1,362 vaccinated people, 3 additional cases of adverse reactions increased to 4 cases. Three cases are one case of fever after vaccination, one case of chills and muscle pain, and one case of bruising at the vaccination site, which are generally identified as adverse reactions at the level that can occur during vaccination. In the case of “pain” that was previously reported as the first adverse reaction, symptoms have improved.
When looking at the status of vaccines by region, Jeonbuk had the most with 326 cases. Next, Gyeonggi 225 cases, Incheon 213 cases, Gyeongbuk 148 cases, Busan 109 cases, Chungnam 74 cases, Seoul 70 cases, Sejong 51 cases, Daegu 46 cases, Gwangju 40 cases, Jeonnam 31 cases, Gyeongnam 10 cases, Daejeon 10 cases , Jeju 8 cases were followed by 1 case in Chungbuk. ◇ 3 adverse reactions added, 4 in total … 1047 out of 1362 vaccines do not meet national commercial guidelinesThe vaccine suspected of being exposed to room temperature, which is currently being verified by the government, is a free vaccine for adults ages 13 to 18 and ages 62 and older. The government stopped the vaccination on the 22nd, but some hospitals carried out the vaccination without discriminating between the amount paid and the free amount. Free and paid flu vaccines only differ in supply, but use the same type of product. Free vaccines for children under 12 years of age and for pregnant women resumed from the afternoon of the 25th.
Of the 1,362 vaccines, the government identified 868 cases (63.7%) of vaccines before the commercial suspension date (22 days, the initial commercial start date) and 315 cases (23.1%) of vaccines when stopped vaccination.
Vaccination cases for the 21 (868 cases) and after the notification date (from 23) (179 cases) are cases of non-compliance with the guidelines of the national influenza vaccination program. However, the vaccination case on the 22nd is considered a vaccination case without knowledge of the business interruption.
◇ Three people died in a nursing hospital in Incheon … Cause of underlying disease, storage at proper temperature for vaccine.
Additionally, three patients at a nursing hospital in Incheon died after receiving the ‘flu vaccine’ that is being investigated by the government. The hospital administered the vaccine to 122 of the 233 hospitalized patients on Day 25.
The deaths were 86-year-old women (died on 26), 88-year-old women (28), and 91-year-old women (29). In this regard, the expert advisory meeting determined that the underlying disease worsened, not vaccination, as the cause of death. No adverse reactions were found in other patients who received the vaccine at this nursing hospital. At the hospital, it was confirmed that an average of 11 to 13 deaths per month occurred over the past two years.
The vaccine that 122 people received is correct for supply from the Shinsung Pharmaceutical Consortium, which was previously reported to have been exposed to room temperature during distribution, but was found to be received, shipped and transported at 2-8 degrees Celsius, which is the optimal storage temperature for the vaccine. DL Farm, a participating company in the consortium, supplied the quantity.
The Agency for Disease Control and Prevention said: “We are continually investigating, confirming and counting use cases of the discontinued quantity through local governments. We will continue to monitor adverse reactions in the future.”
(Seoul = News 1)
Copyright by dongA.com All rights reserved.
